Literature DB >> 24345401

Are we moving towards concordance on the principle that lipid discordance matters?

Seth S Martin1, Erin D Michos.   

Abstract

Entities:  

Keywords:  Editorials; coronary disease; lipids; lipoproteins; low-density lipoprotein cholesterol

Mesh：

Substances：

Year:  2013        PMID： 24345401      PMCID： PMC4286869          DOI： 10.1161/CIRCULATIONAHA.113.007207

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  16 in total

1.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

Authors:  W T Friedewald; R I Levy; D S Fredrickson
Journal:  Clin Chem       Date:  1972-06       Impact factor: 8.327

2.  ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS).

Authors:  Zeljko Reiner; Alberico L Catapano; Guy De Backer; Ian Graham; Marja-Riitta Taskinen; Olov Wiklund; Stefan Agewall; Eduardo Alegria; M John Chapman; Paul Durrington; Serap Erdine; Julian Halcox; Richard Hobbs; John Kjekshus; Pasquale Perrone Filardi; Gabriele Riccardi; Robert F Storey; David Wood
Journal:  Eur Heart J       Date:  2011-06-28       Impact factor: 29.983

3.  Performance of four homogeneous direct methods for LDL-cholesterol.

Authors:  W Greg Miller; Parvin P Waymack; F Philip Anderson; Steven F Ethridge; Eduviges C Jayne
Journal:  Clin Chem       Date:  2002-03       Impact factor: 8.327

4.  Clinical implications of discordance between low-density lipoprotein cholesterol and particle number.

Authors:  James D Otvos; Samia Mora; Irina Shalaurova; Philip Greenland; Rachel H Mackey; David C Goff
Journal:  J Clin Lipidol       Date:  2011 Mar-Apr       Impact factor: 4.766

5.  Discordance between non-HDL-cholesterol and LDL-particle measurements: results from the Multi-Ethnic Study of Atherosclerosis.

Authors:  Emil M Degoma; Mat D Davis; Richard L Dunbar; Emile R Mohler; Philip Greenland; Benjamin French
Journal:  Atherosclerosis       Date:  2013-03-26       Impact factor: 5.162

Review 6.  2012 update of the Canadian Cardiovascular Society guidelines for the diagnosis and treatment of dyslipidemia for the prevention of cardiovascular disease in the adult.

Authors:  Todd J Anderson; Jean Grégoire; Robert A Hegele; Patrick Couture; G B John Mancini; Ruth McPherson; Gordon A Francis; Paul Poirier; David C Lau; Steven Grover; Jacques Genest; André C Carpentier; Robert Dufour; Milan Gupta; Richard Ward; Lawrence A Leiter; Eva Lonn; Dominic S Ng; Glen J Pearson; Gillian M Yates; James A Stone; Ehud Ur
Journal:  Can J Cardiol       Date:  2013-02       Impact factor: 5.223

7.  Concordance/discordance between plasma apolipoprotein B levels and the cholesterol indexes of atherosclerotic risk.

Authors:  Allan D Sniderman; Annie C St-Pierre; Bernard Cantin; Gilles R Dagenais; Jean-Pierre Després; Benoît Lamarche
Journal:  Am J Cardiol       Date:  2003-05-15       Impact factor: 2.778

8.  LDL Particle Number and Risk of Future Cardiovascular Disease in the Framingham Offspring Study - Implications for LDL Management.

Authors:  William C Cromwell; James D Otvos; Michelle J Keyes; Michael J Pencina; Lisa Sullivan; Ramachandran S Vasan; Peter W F Wilson; Ralph B D'Agostino
Journal:  J Clin Lipidol       Date:  2007-12       Impact factor: 4.766

9.  Lipids and risk of coronary heart disease. The Framingham Study.

Authors:  W P Castelli; K Anderson; P W Wilson; D Levy
Journal:  Ann Epidemiol       Date:  1992 Jan-Mar       Impact factor: 3.797

10.  Discordance of low-density lipoprotein (LDL) cholesterol with alternative LDL-related measures and future coronary events.

Authors:  Samia Mora; Julie E Buring; Paul M Ridker
Journal:  Circulation       Date:  2013-12-17       Impact factor: 29.690
View more
  9 in total

1.  Total cholesterol/HDL-cholesterol ratio discordance with LDL-cholesterol and non-HDL-cholesterol and incidence of atherosclerotic cardiovascular disease in primary prevention: The ARIC study.

Authors:  Renato Quispe; Mohamed B Elshazly; Di Zhao; Peter P Toth; Rishi Puri; Salim S Virani; Roger S Blumenthal; Seth S Martin; Steven R Jones; Erin D Michos
Journal:  Eur J Prev Cardiol       Date:  2019-07-10       Impact factor: 7.804

2.  Patient-Level Discordance in Population Percentiles of the Total Cholesterol to High-Density Lipoprotein Cholesterol Ratio in Comparison With Low-Density Lipoprotein Cholesterol and Non-High-Density Lipoprotein Cholesterol: The Very Large Database of Lipids Study (VLDL-2B).

Authors:  Mohamed B Elshazly; Renato Quispe; Erin D Michos; Allan D Sniderman; Peter P Toth; Maciej Banach; Krishnaji R Kulkarni; Josef Coresh; Roger S Blumenthal; Steven R Jones; Seth S Martin
Journal:  Circulation       Date:  2015-07-02       Impact factor: 29.690

3.  Association of apolipoprotein B, LDL-C and vascular stiffness in adolescents with type 1 diabetes.

Authors:  Petter Bjornstad; Nhung Nguyen; Christina Reinick; David M Maahs; Franziska K Bishop; Scott A Clements; Janet K Snell-Bergeon; Rachel Lieberman; Laura Pyle; Stephen R Daniels; R Paul Wadwa
Journal:  Acta Diabetol       Date:  2014-12-25       Impact factor: 4.280

4.  Relation of Combined Non-High-Density Lipoprotein Cholesterol and Apolipoprotein B With Atherosclerosis in Adults With Type 1 Diabetes Mellitus.

Authors:  Petter Bjornstad; Robert H Eckel; Laura Pyle; Marian Rewers; David M Maahs; Janet K Snell-Bergeon
Journal:  Am J Cardiol       Date:  2015-07-16       Impact factor: 2.778

5.  Atherogenic Lipoprotein Subfractions Determined by Ion Mobility and First Cardiovascular Events After Random Allocation to High-Intensity Statin or Placebo: The Justification for the Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin (JUPITER) Trial.

Authors:  Samia Mora; Michael P Caulfield; Jay Wohlgemuth; Zhihong Chen; H Robert Superko; Charles M Rowland; Robert J Glynn; Paul M Ridker; Ronald M Krauss
Journal:  Circulation       Date:  2015-09-25       Impact factor: 29.690

6.  The Use of Blood Biomarkers in Precision Medicine for the Primary Prevention of Atherosclerotic Cardiovascular Disease: a Review.

Authors:  Ty Sweeney; Renato Quispe; Thomas Das; Stephen P Juraschek; Seth S Martin; Erin D Michos
Journal:  Expert Rev Precis Med Drug Dev       Date:  2021-05-26

7.  LDL-cholesterol to HDL-cholesterol ratio discordance with lipid parameters and carotid intima-media thickness: a cohort study in China.

Authors:  Yanmei Lou; Xue Li; Liming Cao; Pei Qin; Jing Shi; Yanyan Zhang; Changyi Wang; Jianping Ma; Li Wang; Xiaolin Peng; Hongen Chen; Shan Xu; Fulan Hu; Yashuang Zhao; Ping Zhao
Journal:  Lipids Health Dis       Date:  2020-06-18       Impact factor: 3.876

8.  Apolipoprotein B discordance with low-density lipoprotein cholesterol and non-high-density lipoprotein cholesterol in relation to coronary artery calcification in the Multi-Ethnic Study of Atherosclerosis (MESA).

Authors:  Jing Cao; Sarah O Nomura; Brian T Steffen; Weihua Guan; Alan T Remaley; Amy B Karger; Pamela Ouyang; Erin D Michos; Michael Y Tsai
Journal:  J Clin Lipidol       Date:  2019-11-29       Impact factor: 4.766

9.  Non-HDL Cholesterol is a More Superior Predictor of Small-Dense LDL Cholesterol than LDL Cholesterol in Japanese Subjects with TG Levels ＜400 mg/dL.

Authors:  Kengo Moriyama; Eiko Takahashi
Journal:  J Atheroscler Thromb       Date:  2016-03-18       Impact factor: 4.928
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.